Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) traded down 0.6% during trading on Friday . The company traded as low as $17.45 and last traded at $17.45. 1,400 shares traded hands during trading, a decline of 34% from the average session volume of 2,108 shares. The stock had previously closed at $17.55.
Shionogi & Co., Ltd. Trading Down 0.6%
The company has a fifty day moving average price of $17.83 and a two-hundred day moving average price of $19.54.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
See Also
- Five stocks we like better than Shionogi & Co., Ltd.
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
